Assessing Feasibility of Evaluating Provider Experience With a Remote Therapeutic Monitoring Platform
1 other identifier
observational
45
1 country
1
Brief Summary
: Remote therapeutic monitoring (RTM) platforms were increasingly deployed in Outpatient Rehabilitation to support continuous, between-visit communication, adherence to home exercise programs, and earlier identification of clinical setbacks. While patient-facing outcomes have received growing attention, evidence describing the clinician experience of RTM; including its effects on therapeutic alliance, perceived cognitive workload, and capacity for proactive patient management remains limited. Understanding how providers perceive and integrate RTM technology into their workflows is essential to optimizing implementation, sustaining adoption, and translating digital health investment into measurable clinical value. This cross-sectional survey study tested the feasibility of evaluating the provider's experience using a digital RTM platform across three pre-specified domains: 1) therapeutic alliance, 2) work satisfaction, plus cognitive loading, and 3) proactive patient management. A secondary objective examined whether years of clinical experience or self-reported comfort with new technology were associated with provider experience or perceived workload.A cross-sectional, anonymous survey was administered to licensed physical therapists at the Outpatient Clinics, Shebin El-Kom, Menofyia governate, Egypt between 1st March, and 31th July, 2026 with a response rate of 43.4% (43/99) for the completed surveys. Eligible clinicians used the SaRA Health RTM platform for at least the previous six months prior to initiation of current study. The survey instrument combined an internally developed 8-item Likert-scale survey (0-5) targeting therapeutic alliance, proactive management, and satisfaction (Cronbach's α = 0.89) with a modified NASA Task Load Index (NASA-TLX; Cronbach's α = 0.86) measured the perceived workload across six domains (0-10). Cronbach's α coefficient demonstrates internal consistency, unless not construct validity or test-retest reliability. Statistical analyses included Spearman rank-order correlations and Mann-Whitney-U tests. For Mann-Whitney comparisons, results were reported as: U, p-value, group sample sizes (N1, N2), and rank-biserial r-effect size. For multiple comparisons across NASA-TLX subscales (k = 6), a Bonferroni-corrected threshold of α = .0083 was applied. Spearman correlations were reported with ρ and 95% confidence intervals.In this cross-sectional survey feasibility study, it was observed that clinician experience with the SaRA Health RTM platform was characterized by enhanced therapeutic alliance when early warning detection performed well, reduced cognitive load was observed when frustration was low, and meaningful facilitation of proactive patient management was observed among engaged users. Frustration emerged as the most actionable lever for design and implementation improvement, and self-reported digital comfort rather than years of clinical experience was the strongest clinician-level correlate of cognitive burden. These findings suggest that targeted onboarding, mentorship, and friction-reducing platform refinements may improve RTM adoption and amplify downstream benefits to patient care. Larger, multi-site, longitudinal studies are warranted to validate these signals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
CompletedFirst Submitted
Initial submission to the registry
August 23, 2026
CompletedFirst Posted
Study publicly available on registry
August 27, 2026
CompletedAugust 27, 2026
August 1, 2026
3 months
August 23, 2026
August 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
A modified, non-validated NASA Task Load Index (NASA-TLX)
A modified, non-validated NASA Task Load Index (NASA-TLX) measures perceived workload of human-machine systems across six domains and has been used extensively in the healthcare field to exam workload for providers using digital health technologies. The validated tool is generally used without modification using a 0-100 scale. We modified the scale to 0-10 with '0' representing the lowest end of each domain. For example, a score of 0 on the mental demand item indicates no additional mental load attributable to the system, whereas a score of '10' indicates extremely high additional mental load. The original instrument served as a template; item wording was lightly modified to reflect the RTM use case more specifically.
1. At base-line of the study.
An internally developed 8-item Likert-scale survey
An internally developed 8-item Likert-scale survey designed by the SaRA Health research team, comprised 8 items rated on a Likert scale from 1 (strongly disagree) to 5 (strongly agree). Items targeted clinician perceptions of therapeutic alliance, proactive patient management, and work satisfaction associated with use of the RTM system.
1. At base-line of the study.
Study Arms (1)
Experimental Group
45 Licensed physical therapists providing Outpatient care to adult patients at the Outpatient Clinics, Shebin El-Kom, Menofyia governate, Egypt, who had used the SaRA Health RTM platform at least six months prior and during the study period. Exclusion: clinicians without direct RTM-platform exposure and respondents with incomplete surveys on key outcome items. Participants represent a range of experience levels and professions. Respondents were asked about their comfort with technology, the number of patient-care hours they delivered weekly, and the proportion of their caseload enrolled on the SaRA Health RTM platform
Interventions
The survey was administered anonymously and consisted of two principal instruments: 1) an internally developed 8-item Likert-scale survey examining clinician experiences with the SaRA Health RTM platform and its perceived contribution to patient care plans, and 2) a modified, non-validated NASA Task Load Index (NASA-TLX) that captured perceived cognitive and physical workload, time pressure, performance (defined as the ability to complete work), effort, and frustration associated with platform use. The validated tool is generally used without modification using a 0-100 scale. We modified the scale to 0-10 with '0' representing the lowest end of each domain. The internally developed survey, designed by the SaRA Health research team, comprised 8 items rated on a Likert scale from 1 (strongly disagree) to 5 (strongly agree). Items targeted clinician perceptions of therapeutic alliance, proactive patient management, and work satisfaction associated with use of the RTM system.
Eligibility Criteria
Clinicians used the SaRA Health RTM platform for at least the previous six months prior to initiation of current study. Licensed physical therapists providing Outpatient care to adult patients at the Outpatient Clinics, Shebin El-Kom, Menofyia governate, Egypt, who had used the SaRA Health RTM platform at least six months prior and during the study period. Exclusion: clinicians without direct RTM-platform exposure and respondents with incomplete surveys on key outcome items.
You may qualify if:
- Licensed physical therapists providing Outpatient care to adult patients at the Outpatient Clinics, Shebin El-Kom, Menofyia governate, Egypt, who had used the SaRA Health RTM platform at least six months prior and during the study period.
- A range of physical therapy experience levels and professions.
- Clinicians used the SaRA Health RTM platform for at least the previous six months prior to initiation of current study.
You may not qualify if:
- Clinicians without direct RTM-platform exposure and respondents with incomplete surveys on key outcome items
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Adly A Adamlead
Study Sites (1)
Shebin ElKom Teaching Hospital
Shibīn al Kawm, Menofyia, 11432, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 45 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Physical Therapy Specialist
Study Record Dates
First Submitted
August 23, 2026
First Posted
August 27, 2026
Study Start
March 1, 2026
Primary Completion
June 1, 2026
Study Completion
July 30, 2026
Last Updated
August 27, 2026
Record last verified: 2026-08